| Lawrence Blair Thrush Jr, MD | |
|
3411a Noyes Ave Se, Charleston, WV 25304 | |
| (304) 344-2459 | |
| (304) 345-1336 |
| Full Name | Lawrence Blair Thrush Jr |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 54 Years |
| Location | 3411a Noyes Ave Se, Charleston, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356333405 | NPI | - | NPPES |
| 000113916 | Other | WV | BCBS |
| 4252011 | Other | WV | AETNA |
| 0070499000 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | 11974 (West Virginia) | Secondary |
| 207K00000X | Allergy & Immunology | 11974 (West Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Thrush And Clark Allergists Pllc | 3870644511 | 3 |
News Archive
Catalyst Health Solutions, Inc. today announced that it plans to sell 5,500,000 shares of its common stock, subject to market and other conditions, of which 4,500,000 shares will be sold by the Company and 1,000,000 shares will be sold by one of its stockholders, Principal Holding Company, LLC, a subsidiary of Principal Financial Group, Inc., in an underwritten public offering pursuant to an automatic shelf registration statement on Form S-3 filed today with the Securities and Exchange Commission.
New data presented at recent neurological congresses and summarized at the IDS indicate that patients treated with XEOMIN for cervical dystonia or blepharospasm (involuntary closing of the eyelids) experienced long-term sustained efficacy with a favorable safety profile in studies of up to 121 and 88 weeks duration, respectively.
Pregnant women who are stressed, particularly late in pregnancy, have an increased risk of their child going on to develop asthma, according to the latest research from Children of the 90s.
Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, announced today that it presented positive results from a Phase 2a study of EP-101 in patients with moderate to severe chronic obstructive pulmonary disease (COPD), a large and growing disease characterized by significant unmet clinical needs, at the annual meeting of the European Respiratory Society.
Washington State Nurses Association, representing more than 300 registered nurses at Public Health - Seattle & King County, is holding an informational picket today to highlight issues critical to public health and safety. During stalled contract negotiations, public health nurses are deeply concerned that the administration's new limitations on work schedules will reduce the ability to meet the needs of patients and clients.
› Verified 2 days ago
| Entity Name | Thrush & Clark Allergists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225118946 PECOS PAC ID: 3870644511 Enrollment ID: O20090619000386 |
News Archive
Catalyst Health Solutions, Inc. today announced that it plans to sell 5,500,000 shares of its common stock, subject to market and other conditions, of which 4,500,000 shares will be sold by the Company and 1,000,000 shares will be sold by one of its stockholders, Principal Holding Company, LLC, a subsidiary of Principal Financial Group, Inc., in an underwritten public offering pursuant to an automatic shelf registration statement on Form S-3 filed today with the Securities and Exchange Commission.
New data presented at recent neurological congresses and summarized at the IDS indicate that patients treated with XEOMIN for cervical dystonia or blepharospasm (involuntary closing of the eyelids) experienced long-term sustained efficacy with a favorable safety profile in studies of up to 121 and 88 weeks duration, respectively.
Pregnant women who are stressed, particularly late in pregnancy, have an increased risk of their child going on to develop asthma, according to the latest research from Children of the 90s.
Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, announced today that it presented positive results from a Phase 2a study of EP-101 in patients with moderate to severe chronic obstructive pulmonary disease (COPD), a large and growing disease characterized by significant unmet clinical needs, at the annual meeting of the European Respiratory Society.
Washington State Nurses Association, representing more than 300 registered nurses at Public Health - Seattle & King County, is holding an informational picket today to highlight issues critical to public health and safety. During stalled contract negotiations, public health nurses are deeply concerned that the administration's new limitations on work schedules will reduce the ability to meet the needs of patients and clients.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lawrence Blair Thrush Jr, MD 3411a Noyes Ave Se, Charleston, WV 25304 Ph: (304) 344-2459 | Lawrence Blair Thrush Jr, MD 3411a Noyes Ave Se, Charleston, WV 25304 Ph: (304) 344-2459 |
News Archive
Catalyst Health Solutions, Inc. today announced that it plans to sell 5,500,000 shares of its common stock, subject to market and other conditions, of which 4,500,000 shares will be sold by the Company and 1,000,000 shares will be sold by one of its stockholders, Principal Holding Company, LLC, a subsidiary of Principal Financial Group, Inc., in an underwritten public offering pursuant to an automatic shelf registration statement on Form S-3 filed today with the Securities and Exchange Commission.
New data presented at recent neurological congresses and summarized at the IDS indicate that patients treated with XEOMIN for cervical dystonia or blepharospasm (involuntary closing of the eyelids) experienced long-term sustained efficacy with a favorable safety profile in studies of up to 121 and 88 weeks duration, respectively.
Pregnant women who are stressed, particularly late in pregnancy, have an increased risk of their child going on to develop asthma, according to the latest research from Children of the 90s.
Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, announced today that it presented positive results from a Phase 2a study of EP-101 in patients with moderate to severe chronic obstructive pulmonary disease (COPD), a large and growing disease characterized by significant unmet clinical needs, at the annual meeting of the European Respiratory Society.
Washington State Nurses Association, representing more than 300 registered nurses at Public Health - Seattle & King County, is holding an informational picket today to highlight issues critical to public health and safety. During stalled contract negotiations, public health nurses are deeply concerned that the administration's new limitations on work schedules will reduce the ability to meet the needs of patients and clients.
› Verified 2 days ago
Chang Hyuk Choi, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 208 Maccorkle Ave Se, Charleston, WV 25314 Phone: 304-343-4300 Fax: 304-343-5473 | |
Chandra Mohan Kumar, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 208 Maccorkle Ave Se, Charleston, WV 25314 Phone: 304-343-4300 Fax: 304-343-5473 | |
James Paul Clark Ii, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3411a Noyes Ave Se, Charleston, WV 25304 Phone: 304-344-2459 Fax: 304-345-1336 | |
Dr. Mary Lind Veloso, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 208 Maccorkle Ave Se, Charleston, WV 25314 Phone: 304-343-4300 Fax: 304-343-5473 | |
Siwat Kiratiseavee, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 208 Maccorkle Ave Se, Charleston, WV 25314 Phone: 304-343-4300 Fax: 304-343-5473 |